Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multi-center study of NRL972 pharmacokinetics in patients with hepatic cirrhosis
2007-002404-18Phase 3Completed
- Sponsor
- Norgine
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fluorescein lisicol in Cirrhosis, sponsored by Norgine. Started Dec 2007; status: completed.
02
Drugs
fluorescein lisicol
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2007-002404-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002404-18.